US 9060941
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
granted A61KA61K31/155A61K31/425
Quick answer
US patent 9060941 (Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative) held by Takeda Pharmaceutical Company Limited expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/155, A61K31/425, A61K31/426, A61K45/06